about
Intracerebral haemorrhage in Down syndrome: protected or predisposed?The role of the lymphatic system in cholesterol transportA genetic cause of Alzheimer disease: mechanistic insights from Down syndromeWhat does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?Is Spontaneous Translocation of Polar Lipids Between Cellular Organelles Negligible?A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretionCyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative DiseasesSR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate CancerApoptotic cells trigger a membrane-initiated pathway to increase ABCA1ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacityABCMdb reloaded: updates on mutations in ATP binding cassette proteins.Erythrodiol, an Olive Oil Constituent, Increases the Half-Life of ABCA1 and Enhances Cholesterol Efflux from THP-1-Derived Macrophages.Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationshipPiperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP-1-derived macrophages.Cellular Localization and Trafficking of the Human ABCG1 TransporterRobust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoproteinThermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.ABCA1 contributes to macrophage deposition of extracellular cholesterol.Structural stability and functional remodeling of high-density lipoproteins.HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.ABCA1-dependent sterol release: sterol molecule specificity and potential membrane domain for HDL biogenesis.Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.Convergent Signaling Pathways Controlled by LRP1 (Receptor-related Protein 1) Cytoplasmic and Extracellular Domains Limit Cellular Cholesterol AccumulationAmphipathic polyproline peptides stimulate cholesterol efflux by the ABCA1 transporter.High-Density Lipoproteins for Therapeutic Delivery Systems.Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.Role of the ABC transporter Mdr49 in Hedgehog signaling and germ cell migration.Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.APOE polymorphisms influence longitudinal lipid trends preceding intracerebral hemorrhageAdvanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterolAcute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivoPlaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cells.High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I LipidationSilymarin Constituents Enhance ABCA1 Expression in THP-1 Macrophages.Lipidomics in vascular health: current perspectives.Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural InsightsCurrent Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
P2860
Q26745369-BDC9C57A-BD3E-46AE-8530-C69734F67D06Q26782973-ADFDA1E3-F470-4352-8A18-46C8FE430B36Q26798983-130A4303-1BFD-421E-816C-3CD681B6A97CQ26821862-7E9B3885-0085-407E-8664-45498E7A22BDQ26822245-5D0003D9-CB16-4AAC-9A36-545F9FD246BFQ26865600-599B7D8C-828E-4A11-9746-7979A3162BF4Q28071254-F37A0B61-8328-4D1C-B270-3F71B62B19A6Q28074790-F2CD21EA-0004-449B-A188-553238B90F6EQ30370661-CB256A45-7CCD-4AF9-86E6-AF7FA4862B9EQ33725659-2620AF61-9DF6-4D99-B365-1BE39A7B031AQ33787550-B65EAFCF-08B5-4B5C-9893-5A91F9B87AE4Q33790275-92BC6C72-3BF7-4A66-B8A2-FD1FB7FA9CA4Q33828806-D5FAB769-424F-441A-A2D6-0276A148F3C7Q34545047-58D0D7CC-A851-4E40-A35B-639EFD373484Q34792398-12914493-C7C7-4FAE-8900-C4615C8265F0Q35536400-397ACB89-1944-499E-8008-5D87A0BA3CF4Q35886290-D8001895-C5D3-4F09-B49D-514402BDE7F3Q35978258-6152FB27-8650-4862-8A4D-DB71B0FCACFAQ35994360-0596B315-19F9-4516-ACEC-D0486027ABD0Q36031087-2156F459-B9A2-4269-B9B6-FC13B90F6180Q36093194-0796605E-BCAA-4546-94C4-C68B76417DD9Q36197563-42BEA13D-CF2E-41A2-B1B8-C3A0A45048DDQ36399247-F75D285E-EBD8-4B78-A711-D74B315AE1A8Q36560360-2F7DCD07-118B-4CE5-BC40-EB78D21F27BFQ36650322-3C3CFE9C-D7FA-4A9F-B1BF-AF2CCF43245EQ36761029-B6549722-5B63-488F-8E61-7D66FEFDC9B0Q36781321-5CB38474-0D90-491A-8B96-CA0F5A6E0E67Q36984213-E2B53E70-4AAE-4857-963F-14B6F66EA4D7Q37036235-A9544951-411A-467B-A8F6-3B4E41F8BF96Q37037342-91F735AC-D23A-4968-98EA-D1348C345E0DQ37074302-862F0EFB-AC0C-405D-AA79-ED0698134360Q37267563-8E476490-0A6A-419A-A15B-E8E8310226D7Q37270341-7502188F-A86F-48D0-8B14-4CC9C5A79AE4Q37594660-066E6A47-976C-4485-91BB-335AA13E2465Q37691638-8B0CBAE7-1CA4-4307-9644-91FB33CCBC72Q37708455-D63509F2-2241-4ABD-B959-7541C0034780Q38336287-CBBC0A30-4D55-4665-87A1-5131B325747EQ38537535-AD97737E-43C7-4C39-AB70-49641264057DQ38543425-B45FC276-3BC7-44CA-955D-B93890DFA107Q38546242-9037A927-FA8E-4CB9-B60C-D6960C04B8E8
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular mechanisms of cellular cholesterol efflux
@ast
Molecular mechanisms of cellular cholesterol efflux
@en
Molecular mechanisms of cellular cholesterol efflux
@nl
type
label
Molecular mechanisms of cellular cholesterol efflux
@ast
Molecular mechanisms of cellular cholesterol efflux
@en
Molecular mechanisms of cellular cholesterol efflux
@nl
prefLabel
Molecular mechanisms of cellular cholesterol efflux
@ast
Molecular mechanisms of cellular cholesterol efflux
@en
Molecular mechanisms of cellular cholesterol efflux
@nl
P2860
P3181
P356
P1476
Molecular mechanisms of cellular cholesterol efflux
@en
P2093
M. C. Phillips
P2860
P304
24020-24029
P3181
P356
10.1074/JBC.R114.583658
P407
P577
2014-08-29T00:00:00Z